-
Bachelder R E, Bilancieri J, Lin W. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4[J]. J Virol, 1995, 69(): 5734-5742.
-
Baker K A, Dutch R E, Lamb R A. Structural basis for paramyxovirus-mediated membrane fusion[J]. Mol Cell, 1999, 3(): 309-319. doi: 10.1016/S1097-2765(00)80458-X
-
Bisht H, Roberts A, Vogel L. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice[J]. Proc Natl Acad Sci USA, 2004, 101(): 6641-6646. doi: 10.1073/pnas.0401939101
-
Brindley M A, Hughes L, Ruiz A. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events[J]. J Virol, 2007, 81(): 7702-7709. doi: 10.1128/JVI.02433-06
-
Bullough P A, Hughson F M, Skehel J J. Structure of influenza haemagglutinin at the pH of membrane fusion[J]. Nature, 1994, 371(): 37-43. doi: 10.1038/371037a0
-
Caffrey M. Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop[J]. Biochim Biophys Acta, 2001, 1536(): 116-122. doi: 10.1016/S0925-4439(01)00042-4
-
Carr C M, Kim P S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin[J]. Cell, 1993, 73(): 823-832. doi: 10.1016/0092-8674(93)90260-W
-
Colman P M, Lawrence M C. The structural biology of type Ⅰ viral membrane fusion[J]. Nat Rev Mol Cell Biol, 2003, 4(): 309-319. doi: 10.1038/nrm1076
-
Connor R I, Chen B K, Choe S. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes[J]. Virology, 1995, 206(): 935-944. doi: 10.1006/viro.1995.1016
-
Fass D, Blacklow S C, Kim P S. Retrovirus envelope domain at 1.7A0 resolution[J]. Nature Struct Biol, 1996, 3(): 465-469. doi: 10.1038/nsb0596-465
-
Gallaher W R. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses[J]. Cell, 1996, 85(): 477-478. doi: 10.1016/S0092-8674(00)81248-9
-
Higginbottom A, Quinn E R, Kuo C C. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 [In Process Citation][J]. J Virol, 2000, 74(): 3642-3649. doi: 10.1128/JVI.74.8.3642-3649.2000
-
Jeffers S A, Sanders D A, Sanchez A. Covalent modifications of the ebola virus glycoprotein[J]. J Virol, 2002, 76(): 12463-12472. doi: 10.1128/JVI.76.24.12463-12472.2002
-
Kao C C, Yang X, Kline A. Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase[J]. J Virol, 2000, 74(): 11121-11128. doi: 10.1128/JVI.74.23.11121-11128.2000
-
Kuhn J H, Radoshitzky S R, Guth A C. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor[J]. J Biol Chem, 2006, 281(): 15951-15958. doi: 10.1074/jbc.M601796200
-
Lee J E, Fusco M L, Hessell A J. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor[J]. Nature, 2008, 454(): 177-182. doi: 10.1038/nature07082
-
Ma M, Kersten D B, Kamrud K I. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism[J]. Virus Res, 1999, 64(): 23-32. doi: 10.1016/S0168-1702(99)00070-2
-
Malashkevich V N, Chan D C, Chutkowski C T. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides[J]. Proc Natl Acad Sci U S A, 1998, 95(): 9134-9139. doi: 10.1073/pnas.95.16.9134
-
Malashkevich V N, Schneider B J, McNally M L. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution[J]. Proc Natl Acad Sci USA, 1999, 96(): 2662-2667. doi: 10.1073/pnas.96.6.2662
-
Manicassamy B, Wang J, Jiang H. Comprehensive Analysis of Ebola Virus GP1 in Viral Entry[J]. J Virol, 2005, 79(): 4793-4805. doi: 10.1128/JVI.79.8.4793-4805.2005
-
Manicassamy B, Wang J, Rumschlag E. Characterization of Marburg virus glycoprotein in viral entry[J]. Virology, 2007, 358(): 79-88. doi: 10.1016/j.virol.2006.06.041
-
Medina M F, Kobinger G P, Rux J. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung[J]. Mol Ther, 2003, 8(): 777-789. doi: 10.1016/j.ymthe.2003.07.003
-
Mpanju O M, Towner J S, Dover J E. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry[J]. Virus Res, 2006, 121(): 205-214. doi: 10.1016/j.virusres.2006.06.002
-
Neumann G, Feldmann H, Watanabe S. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture[J]. J Virol, 2002, 76(): 406-410. doi: 10.1128/JVI.76.1.406-410.2002
-
Prehaud C, Hellebrand E, Coudrier D. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections[J]. J Gen Virol, 1998, 79(Pt 11): 2565-2572.
-
Rong L, Bates P. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry[J]. J Virol, 1995, 69(): 4847-4853.
-
Rong L, Gendron K, Strohl B. Characterization of determinants for envelope binding and infection in Tva, the subgroup A avian sarcoma and leukosis virus receptor[J]. J Virol, 1998, 72(): 4552-4559.
-
Russell C J, Kantor K L, Jardetzky T S. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion[J]. J Cell Biol, 2003, 163(): 363-374. doi: 10.1083/jcb.200305130
-
Sanchez A, Khan A S, Zaki S R, et al. 2001. Filoviridae: Marburg and Ebola Viruses. In: Fields Virology (Knipe D M, Howley P M. ed. ), 4th ed, vol. 1. Lippicott Williams & Wilkins, Philadelphia, PA. p1279-1304.
-
Sanchez A, Kiley M P, Holloway B P. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus[J]. Virus Res, 1993, 29(): 215-240. doi: 10.1016/0168-1702(93)90063-S
-
Sanchez A, Trappier S G, Mahy B W. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing[J]. Proc Natl Acad Sci USA, 1996, 93(): 3602-3607. doi: 10.1073/pnas.93.8.3602
-
Sanchez A, Trappier S G, Stroher U. Variation in the glycoprotein and VP35 genes of Marburg virus strains[J]. Virology, 1998, 240(): 138-146. doi: 10.1006/viro.1997.8902
-
Simmons G, Wool-Lewis R J, Baribaud F. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence[J]. J Virol, 2002, 76(): 2518-2528. doi: 10.1128/jvi.76.5.2518-2528.2002
-
Takada A, Feldmann H, Stroeher U. Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses[J]. J Virol, 2003, 77(): 1069-1074. doi: 10.1128/JVI.77.2.1069-1074.2003
-
Takada A, Robison C, Goto H. A system for functional analysis of Ebola virus glycoprotein[J]. Proc Natl Acad Sci USA, 1997, 94(): 14764-14769. doi: 10.1073/pnas.94.26.14764
-
Volchkov V E, Becker S, Volchkova V A. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases[J]. Virology, 1995, 214(): 421-430. doi: 10.1006/viro.1995.0052
-
Volchkov V E, Blinov V M, Netesov S V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses[J]. FEBS Lett, 1992, 305(): 181-184. doi: 10.1016/0014-5793(92)80662-Z
-
Weissenhorn W, Dessen A, Harrison S C. Atomic structure of the ectodomain from HIV-1 gp41[J]. Nature, 1997, 387(): 426-430. doi: 10.1038/387426a0
-
Weissenhorn W, Calder L J, Wharton S A. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil[J]. Proc Natl Acad Sci USA, 1998, 95(): 6032-6036. doi: 10.1073/pnas.95.11.6032
-
Wilson I A, Skehel J J, Wiley D C. Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3A resolution[J]. Nature, 1981, 289(): 366-373. doi: 10.1038/289366a0